ACCESS Newswire

CGFNS International

23.2.2024 21:03:16 CET | ACCESS Newswire | Press release

Share
CGFNS International Unveils New Think Tank to Advance Health Workforce Development Scholarship and Solutions Worldwide

PHILADELPHIA, PA / ACCESSWIRE / February 23, 2024 / CGFNS International announced today it has established a Global Health Workforce Development Institute. The new think tank will conduct original research and leverage knowledge developed by CGFNS over its half-century of providing credentialing services -- as well as its vast experience with workforce mobility issues -- to advance scientific knowledge about the evolution of health workforce roles and the development of credentialing and certification programs and policies.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
CGFNS International

A long-term objective of the Institute will be to create rigorous global certification programs that streamline the assessment and recognition of practice competency. These will empower nurses and other health professionals around the world to achieve "work-readiness" regardless of where they choose to apply their knowledge and skills, while enabling them to showcase their competencies to employers, regulators, and educators worldwide.

"Amid an unprecedented health workforce crisis, and with an increasing number of health workers being displaced by the impacts of climate change and armed conflict, the patchwork quilt of standards and qualifications between countries threatens to prevent health workers from practicing to their capacities, much less helping to alleviate workforce shortages in high-need countries and improve healthcare access for underserved populations," said Peter Preziosi, President and CEO of CGFNS.

"This new Institute will be the centerpiece of our effort to address this challenge and ease mobility for health workers to practice where they want and where they are needed," he added.

Leading the new Institute as its Chief is Julia To Dutka, EdD, a renowned global expert and strategist in credential assessment and global labor mobility who is widely published in the fields of education, regulation, and language teaching and testing. Dr. To Dutka brings to the Institute a unique integration of experience from her many years of service at CGFNS, as well as from higher education and from the assessment industry, where she has led large-scale global assessment initiatives.

The Institute will comprise three centers of excellence:

  • The Center for Global Assessment and Certification will lead efforts in the setting of global standards and assessment of competencies in the health professions. Its senior director, Joseph McClintock, PhD, has more than 20 years' experience in all aspects of certification and educational assessment, including test design and creation, item and test development, standards setting and job task analysis. He joins the Institute after serving as vice president of Measurement, Inc., a leading provider of customized educational assessment services.
  • The Center for Knowledge Management will manage CGFNS International's extensive international education and health regulatory databases, along with other knowledge assets, with a focus on leveraging the educational and regulatory data to advance initiatives, policies and further research in global health workforce development. Its senior director, Emily Tse, MPhil, is a recognized expert in the credential evaluation field who previously managed the Country Index series on educational systems around the world at the International Education Research Foundation (IERF).
  • The Center for Global Research and Policy will catalyze a robust research and development agenda and contribute to global human resources for health scholarship through inquiry around global health workforce development, care delivery, and lifelong learning issues. Its senior director, Lauren Herckis, PhD, joins CGFNS from the faculty of Carnegie Mellon University, where she has led interdisciplinary research efforts focused on evidence-based practice for using emerging educational technologies across diverse cultural contexts.

"With our nearly 50-year mission of evaluating nurses and allied health professionals who have chosen to live and work in their country of choice through assessment protocols centering on academic and professional credentials, it is time for CGFNS to recommit itself to improving the health and well-being of the world's populations," said To Dutka. "The Institute will enable CGFNS to serve as a thought leader, to advance new and innovative certification systems, and to support models of care delivery that will accelerate health workforce growth and evolution worldwide."

About CGFNS International, Inc.

Founded in 1977 and based in Philadelphia, CGFNS International is an immigration-neutral not-for-profit organization proudly serving as the world's largest credentials evaluation organization for the nursing and allied health professions. CGFNS International is an NGO in Consultative Status with the United Nations Economic and Social Council (ECOSOC) and is a member of the Conference of NGOs in Consultative Relationship with the United Nations (CoNGO).

Contact Information:

David St. John
dstjohn@cgfns.org

SOURCE: CGFNS International

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

GoodData Kicks Off 2026 with MCP Server Launch and Major Enterprise Wins15.4.2026 12:00:00 CEST | Press release

Financial services wins and three platform launches signal accelerating enterprise demand for agentic analytics. SAN FRANCISCO, CA / ACCESS Newswire / April 15, 2026 / GoodData, a leading AI-native decision intelligence platform, today announced strong Q1 2026 results driven by the launch of its MCP Server for agentic analytics, significant new contracts in global financial services, and continued expansion into new markets. The quarter built on a record-breaking 2025, reinforcing GoodData's position as the platform enterprises trust to move AI from pilot to production. Continued growth across enterprise and financial services GoodData's commercial momentum remained strong throughout Q1, with notable wins across the enterprise and financial sectors. The company secured a new three-year contract with one of the world's largest asset managers, and a key long-term customer in global payments renewed for three years while expanding its enterprise license. "Our Q1 results demonstrate that t

GoodData Kicks Off 2026 with MCP Server Launch and Major Enterprise Wins15.4.2026 12:00:00 CEST | Press release

Financial services wins and three platform launches signal accelerating enterprise demand for agentic analytics. SAN FRANCISCO, CA / ACCESS Newswire / April 15, 2026 / GoodData, a leading AI-native decision intelligence platform, today announced strong Q1 2026 results driven by the launch of its MCP Server for agentic analytics, significant new contracts in global financial services, and continued expansion into new markets. The quarter built on a record-breaking 2025, reinforcing GoodData's position as the platform enterprises trust to move AI from pilot to production. Continued growth across enterprise and financial services GoodData's commercial momentum remained strong throughout Q1, with notable wins across the enterprise and financial sectors. The company secured a new three-year contract with one of the world's largest asset managers, and a key long-term customer in global payments renewed for three years while expanding its enterprise license. "Our Q1 results demonstrate that t

OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies15.4.2026 10:40:00 CEST | Press release

Poster Presentations featuring the latest advancements on anti-TROP2 (OBI 902) and Nectin-4 (OBI 904) ADCs, anti-TROP2/HER2 BsADC (OBI 201), anti-cMET/HER3Bs-Dual Payload ADC (OBI 221),and OBI's novel Obrion ™ ADC enabling technologies(GlycOBI ® and GlycOBI DUO ®). TAIPEI, TW / ACCESS Newswire / April 15, 2026 / OBI Pharma, Inc. (TPEx:4174.TWO) today announced its presence at AACR 2026, highlighted by ten poster presentations, showcasing the transformative potential of the GlycOBI® platform. Conventional ADCs often face limitations due to random conjugation, resulting in heterogeneous Drug-to-Antibody Ratios (DAR), suboptimal stability, and narrow therapeutic windows. In contrast, the OBI site-specific glycan-based technology enables a highly homogeneous DAR, translating into improved PK/PD profiles, and reduced off-target toxicity, as demonstrated by OBI's lead programs, OBI-902 and OBI-904. We are further advancing precision oncology through our next-generation bispecific (OBI-201) a

OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies15.4.2026 10:40:00 CEST | Press release

Poster Presentations featuring the latest advancements on anti-TROP2 (OBI 902) and Nectin-4 (OBI 904) ADCs, anti-TROP2/HER2 BsADC (OBI 201), anti-cMET/HER3Bs-Dual Payload ADC (OBI 221),and OBI's novel Obrion ™ ADC enabling technologies(GlycOBI ® and GlycOBI DUO ®). TAIPEI, TW / ACCESS Newswire / April 15, 2026 / OBI Pharma, Inc. (TPEx:4174.TWO) today announced its presence at AACR 2026, highlighted by ten poster presentations, showcasing the transformative potential of the GlycOBI® platform. Conventional ADCs often face limitations due to random conjugation, resulting in heterogeneous Drug-to-Antibody Ratios (DAR), suboptimal stability, and narrow therapeutic windows. In contrast, the OBI site-specific glycan-based technology enables a highly homogeneous DAR, translating into improved PK/PD profiles, and reduced off-target toxicity, as demonstrated by OBI's lead programs, OBI-902 and OBI-904. We are further advancing precision oncology through our next-generation bispecific (OBI-201) a

IDC Defines the Next Era of Technology Intelligence with the Introduction of IDC Quanta(TM) at Directions 20268.4.2026 17:15:00 CEST | Press release

New AI-powered platform establishes an embedded intelligence layer for the AI economy, delivering decision-grade insight BOSTON, MA / ACCESS Newswire / April 8, 2026 / IDC today opened IDC Directions 2026, its flagship client event, bringing together technology leaders, analysts, and industry experts to examine the forces reshaping the global technology market and to introduce a major evolution in how technology intelligence is delivered. At the center of this year's event is IDC Quanta™, a new AI-powered platform that establishes what IDC defines as the technology intelligence layer for the AI economy. As artificial intelligence accelerates the pace of business and compresses decision cycles, IDC is redefining its role from a destination for research and data to an embedded intelligence capability that delivers trusted insight directly into the workflows where decisions are made. "AI is compressing time across the entire technology market, and that breaks the traditional research mode

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye